General Information of the Compound
Compound ID
CP0571435
Compound Name
4-(azetidin-1-yl)-N-[[2-chloro-4-(methanesulfonamido)phenyl]methyl]benzamide
    Show/Hide
Structure
Formula
C18H20ClN3O3S
Molecular Weight
393.896
Canonical SMILES
CS(=O)(=O)Nc1ccc(CNC(=O)c2ccc(cc2)N2CCC2)c(Cl)c1
    Show/Hide
InChI
InChI=1S/C18H20ClN3O3S/c1-26(24,25)21-15-6-3-14(17(19)11-15)12-20-18(23)13-4-7-16(8-5-13)22-9-2-10-22/h3-8,11,21H,2,9-10,12H2,1H3,(H,20,23)
    Show/Hide
InChIKey
AAKFEGALHSLAOA-UHFFFAOYSA-N
Physicochemical Property
logP
2.8516
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
78.51
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166626811
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 13000 nM
   TI
   LI
   LO
   TS